Hormone therapy is considered safe and effective for hot flashes in otherwise healthy women under 60 or within 10 years of menopause. That is the main takeaway of a 2026 review on menopause hormone therapy. It looked at earlier research, including a fresh look at the Women’s Health Initiative. It also covered recent studies of women during and after menopause. This was a review, not a new treatment study. For our Progesterone community, one key detail is how hormones are taken. Hormone treatment taken by mouth raises the risk of blood clots in veins. Estrogen delivered through the skin with micronized Progesterone did not appear to raise that risk. Micronized means the hormone is made into very small particles. That finding does not mean every hormone product has the same risks. The review also reported benefits of estrogen for heart and bone health. These were especially relevant when treatment started before age 60. Hormone therapy may also help with mood problems around menopause. The source summary gives no percentages for these benefits or clot risks. Still, symptom relief is different from disease prevention. Major medical groups do not yet recommend menopause hormone therapy solely to prevent disease. For members tracking blood levels, this review offers context rather than a target number. It does not give a Progesterone blood level linked to better results. When comparing notes, age, years since menopause, and treatment form add useful context. Symptom records alongside bloodwork can help describe each person’s experience without proving what caused a change. What changes have you noticed in your symptoms or Progesterone numbers during menopause hormone therapy?